Indole-3-acetic acid, 3-Indolepropionic acid, Illinois–Indiana–Iowa League

Indole-3-acetic acid: ʻO ka Indole-3-acetic acid ka mea maʻamau i ulu maoli i ka hormona o ka papa auxin. ʻO ia ka mea i ʻike nui ʻia o nā auxins, a ua lilo ia i kumuhana o nā noiʻi ākea e nā meaola lāʻau. ʻO ka IAA kahi mea i loaʻa mai ka indole, i loaʻa kahi carboxymethyl substituent. He paʻa kala ʻole ia e hoʻonā ʻia i nā mea hoʻoheheʻe ʻia polar.
3-Indolepropionic acid: ʻO 3-Indolepropionic acid ( IPA ), a i ʻole indole-3-propionic acid , kahi antioxidant neuroprotective ikaika, mea kanu auxin, a me nā huahana kūlohelohe i nā kānaka e aʻo ʻia nei no ka hoʻohana therapeutic i ka maʻi o Alzheimer. Hana ʻia ia e ka microbiota kanaka a ʻike wale ʻia i loko o ka vivo ke loaʻa ka ʻano Clostridium sporogenes i ka gastrointestinal tract. I ka lā o ʻApelila 2016, ʻo C. sporogenes , ka mea e hoʻohana nei i ka tryptophan e synthesize i ka IPA, ʻo ia wale nō nā ʻano bacteria i ʻike ʻia e synthesize i ka IPA i loko o ka vivo ma nā pae i hiki ke ʻike ʻia i ka plasma koko o ka mea hoʻokipa.
Ilinoi – Indiana –Iowa Hui Pū ʻIa: He hui Baseball League Minor ka Hui ʻIlika – Indiana – ʻIowa i hana no ka hapa ʻoi aku o 60 mau makahiki, ka hapa nui i loko o kēlā mau mokuʻāina ʻekolu. Ua hoʻomaka ka pāʻani ma 1901 a ua hemo ma hope o ke kau 1961. Kaulana nui ʻia ʻo ia ʻo ka ʻAkolu – I Hui Pū ʻIa a i kekahi manawa me ka hoʻomākeʻaka ʻana e like me ka Hui ʻEkolu maka .
ʻAila 3-I-Hoʻokahi: ʻO ka aila 3-i-Hoʻokahi kahi aila lubricating kumu nui i kūʻai ʻia aku no ka home a hoʻohana-iā-ʻoe iho. Ua hana mua ʻia ia i ka makahiki 1894 no ka hoʻohana ma nā paikikala, a ke waiho nei he lubricant kaulana no kā lākou kaulahao. ʻO kona inoa, i hāʻawi ʻia e ka mea haku ʻo George W. Cole o New Jersey i ka makahiki 1894, e hōʻike ana i ka hiki i ka huahana o ka huahana ke "hoʻomaʻemaʻe, lubricate a pale".
Indole-3-carboxaldehyde: ʻO Indole-3-carboxaldehyde ( I3A ), i ʻike ʻia ʻo indole-3-aldehyde a me 3-formylindole , kahi metabolite o ka papaʻai L -tr Egyptophan i synthesize ʻia e nā koʻohune gastrointestinal kanaka, ʻo ia hoʻi nā lāhui o Lactobacillus . ʻO ka I3A kahi metabolite hana biologically e hana ma ke ʻano he agonist receptor ma ka aryl hydrocarbon receptor i loko o nā ʻōnaehana immune ʻōpū, a laila e hoʻoulu ai i ka hana o interleukin-22 e kōkua ai i ka hana hou ʻana o ka mucosal.
3-Indolepropionic acid: ʻO 3-Indolepropionic acid ( IPA ), a i ʻole indole-3-propionic acid , kahi antioxidant neuroprotective ikaika, mea kanu auxin, a me nā huahana kūlohelohe i nā kānaka e aʻo ʻia nei no ka hoʻohana therapeutic i ka maʻi o Alzheimer. Hana ʻia ia e ka microbiota kanaka a ʻike wale ʻia i loko o ka vivo ke loaʻa ka ʻano Clostridium sporogenes i ka gastrointestinal tract. I ka lā o ʻApelila 2016, ʻo C. sporogenes , ka mea e hoʻohana nei i ka tryptophan e synthesize i ka IPA, ʻo ia wale nō nā ʻano bacteria i ʻike ʻia e synthesize i ka IPA i loko o ka vivo ma nā pae i hiki ke ʻike ʻia i ka plasma koko o ka mea hoʻokipa.
3-Indolepropionic acid: ʻO 3-Indolepropionic acid ( IPA ), a i ʻole indole-3-propionic acid , kahi antioxidant neuroprotective ikaika, mea kanu auxin, a me nā huahana kūlohelohe i nā kānaka e aʻo ʻia nei no ka hoʻohana therapeutic i ka maʻi o Alzheimer. Hana ʻia ia e ka microbiota kanaka a ʻike wale ʻia i loko o ka vivo ke loaʻa ka ʻano Clostridium sporogenes i ka gastrointestinal tract. I ka lā o ʻApelila 2016, ʻo C. sporogenes , ka mea e hoʻohana nei i ka tryptophan e synthesize i ka IPA, ʻo ia wale nō nā ʻano bacteria i ʻike ʻia e synthesize i ka IPA i loko o ka vivo ma nā pae i hiki ke ʻike ʻia i ka plasma koko o ka mea hoʻokipa.
Indole-3-acetic acid: ʻO ka Indole-3-acetic acid ka mea maʻamau i ulu maoli i ka hormona o ka papa auxin. ʻO ia ka mea i ʻike nui ʻia o nā auxins, a ua lilo ia i kumuhana o nā noiʻi ākea e nā meaola lāʻau. ʻO ka IAA kahi mea i loaʻa mai ka indole, i loaʻa kahi carboxymethyl substituent. He paʻa kala ʻole ia e hoʻonā ʻia i nā mea hoʻoheheʻe ʻia polar.
Indole-3-acetic acid: ʻO ka Indole-3-acetic acid ka mea maʻamau i ulu maoli i ka hormona o ka papa auxin. ʻO ia ka mea i ʻike nui ʻia o nā auxins, a ua lilo ia i kumuhana o nā noiʻi ākea e nā meaola lāʻau. ʻO ka IAA kahi mea i loaʻa mai ka indole, i loaʻa kahi carboxymethyl substituent. He paʻa kala ʻole ia e hoʻonā ʻia i nā mea hoʻoheheʻe ʻia polar.
Indoxyl sulfate: ʻO Indoxyl sulfate , ʻike ʻia ʻo 3-indoxylsulfate a me 3-indoxylsulfuric acid , kahi metabolite o ka papaʻai L -tr Egyptophan e hana nei ma ke ʻano he cardiotoxin a me urin toxin. ʻO nā kiʻekiʻe kiʻekiʻe o ka indoxyl sulfate i ka plasma koko ʻike ʻia e pili pū me ka ulu ʻana a me ka holomua ʻana o ka maʻi puʻuwai mau a me nā maʻi vaskular i loko o kānaka. Ma ke ʻano he toxin uremike, hoʻoulu ia i ka scomerosis glomerular a me ka fibrosis interstitial renal.
Indoxyl sulfate: ʻO Indoxyl sulfate , ʻike ʻia ʻo 3-indoxylsulfate a me 3-indoxylsulfuric acid , kahi metabolite o ka papaʻai L -tr Egyptophan e hana nei ma ke ʻano he cardiotoxin a me urin toxin. ʻO nā kiʻekiʻe kiʻekiʻe o ka indoxyl sulfate i ka plasma koko ʻike ʻia e pili pū me ka ulu ʻana a me ka holomua ʻana o ka maʻi puʻuwai mau a me nā maʻi vaskular i loko o kānaka. Ma ke ʻano he toxin uremike, hoʻoulu ia i ka scomerosis glomerular a me ka fibrosis interstitial renal.
Indoxyl sulfate: ʻO Indoxyl sulfate , ʻike ʻia ʻo 3-indoxylsulfate a me 3-indoxylsulfuric acid , kahi metabolite o ka papaʻai L -tr Egyptophan e hana nei ma ke ʻano he cardiotoxin a me urin toxin. ʻO nā kiʻekiʻe kiʻekiʻe o ka indoxyl sulfate i ka plasma koko ʻike ʻia e pili pū me ka ulu ʻana a me ka holomua ʻana o ka maʻi puʻuwai mau a me nā maʻi vaskular i loko o kānaka. Ma ke ʻano he toxin uremike, hoʻoulu ia i ka scomerosis glomerular a me ka fibrosis interstitial renal.
Indoxyl sulfate: ʻO Indoxyl sulfate , ʻike ʻia ʻo 3-indoxylsulfate a me 3-indoxylsulfuric acid , kahi metabolite o ka papaʻai L -tr Egyptophan e hana nei ma ke ʻano he cardiotoxin a me urin toxin. ʻO nā kiʻekiʻe kiʻekiʻe o ka indoxyl sulfate i ka plasma koko ʻike ʻia e pili pū me ka ulu ʻana a me ka holomua ʻana o ka maʻi puʻuwai mau a me nā maʻi vaskular i loko o kānaka. Ma ke ʻano he toxin uremike, hoʻoulu ia i ka scomerosis glomerular a me ka fibrosis interstitial renal.
3-Iodothyronamine: 3-Iodothyronamine ( T 1 AM ) kahi thyronamine hopena. ʻO T 1 AM kahi ligand affinity kiʻekiʻe no ka receptor pili i ka amine TAAR1 (TAR1, TA1), kahi mea loaʻa hou i loaʻa i ka protein G me ka mea loaʻa pū kekahi. ʻO T 1 AM ka endonous TAAR1 agonist mana loa i ʻike ʻia. ʻO ka hoʻoulu ʻana o TAAR1 e T 1 AM nā hopena i ka hana ʻana i nā nui o cAMP. Hoʻopili ʻia kēia hopena me ka hōʻemi ʻana o ka mahana o ke kino a me ka hopena o ka naʻau. ʻO Wu et al. Ua kuhikuhi aku ʻaʻole pili kēia pilina i ka ʻōnaehana endocrine, e hōʻike ana ʻaʻole e hoʻopili ʻia ka hana a TAAR1 i nā protein G i loko o kekahi mauʻaʻaʻa, a i ʻole hiki ke launa pū ʻo T 1 AM me nā subtypes receptor ʻē aʻe.
3-Iodotyrosine: ʻO 3-Iodotyrosine kahi mea waena i ka synthesite o nā homone thyroid i loaʻa mai ka iodination o tyrosine ma ke kūlana meta o ke apo benzene. Hiki i kahi anakahi ke hui pū me diiodotyrosine e hana ai i triiodothyronine, e like me ka mea i loaʻa i ka colloid o ka thyroid follicle. Hiki i nā ʻāpana ʻelua ke hoʻohui e hana i 3,3'-diiodothyronine.
3-hao: ʻO 3-Iron kahi kiʻi ʻoniʻoni pilialoha 2004 i kākau ʻia, hana ʻia a alakaʻi ʻia e Kim Ki-duk. ʻO kahi hui pū ʻana o ka honua ma waena o Kōlea Hema a me Iapana, nā hōkū kiʻi ʻo Jae Hee ma ke ʻano he drifter ʻōpio nāna e hoʻomohala i kahi pilina me ka wahine wahine i hoʻomāinoino ʻia. Loaʻa ke poʻo inoa o ke kiʻi ʻoniʻoni mai kahi ʻano kolepa kolepa i hoʻohana nui ʻia i loko o ka moʻolelo.
3-Isobutyl-2-methoxypyrazine: ʻO ka 3-Isobutyl-2-methoxypyrazine kahi methoxypyrazine e like loa me ka isopropyl methoxy pyrazine koe wale nō ka ʻaoʻao alkyl i kahi hui isobutyl i hoʻopili ʻia i ka alpha kalapona i ka ʻaoʻao methoxy ma kahi o ka hui ʻaoʻao isopropyl ma kēlā kūpana kūmona like. .
Isophorone diisocyanate: ʻO Isophorone diisocyanate ( IPDI ) kahi hui kūlohelohe i ka papa i ʻike ʻia ʻo isocyanates. ʻO kahi kikoʻī, he diisocyanate aliphatic ia. Hana ʻia ia i nā mea liʻiliʻi, e helu ana no 3.4% wale nō o ka mākeke diisocyanate honua i ka makahiki 2000. Hoʻohana ʻia nā Aliphatic diisocyanates, ʻaʻole i ka hana ʻana o ka hua polyurethane, akā i nā noi kūikawā, e like me nā uhi enamel e kūʻē i ka abrasion a me ka hoʻohaʻahaʻa ʻana mai ke kukui ultraviolet. Makemake nui ʻia kēia mau waiwai i, no ka laʻana, ka pena waho i hoʻopili ʻia i nā mokulele.
ʻO Isopropyl methoxy pyrazine: ʻO Isopropyl methoxy pyrazine ( IPMP ) kahi methoxypyrazine, kahi papa o nā mea hoʻohui kemika e hana i nā pilau. ʻAʻole makemake ʻia ka pilau a hua ʻia e ka nūnū wahine ʻAsia a i ʻole ka actinomycete Streptomyces sp. Hiki ke ʻike ʻia e ka ʻono a ke kanaka i nā noonoo o nā haʻahaʻa o 2 nanogram i kēlā me kēia lita.
3-Isopropylmalate dehydratase: ʻO ka 3-Isopropylmalate dehydratase (EC4.2.1.33) kahi homologue aconitase, kahi e catalyses i ka isomerisation o 2-isopropylmalate i 3-isopropylmalate, ma o ka dehydration, i ka biosynthesis o leucine.
3-Isopropylmalate dehydrogenase: ʻO ka 3-Isopropylmalate dehydrogenase (EC 1.1.1.85 ) kahi enzyme e catalyzed i nā hopena kemika (2R, 3S) -3-isopropylmalate + NAD + 4-methyl-2-oxopentanoate + CO 2 + NADH (2R, 3S) -3-isopropylmalate + NAD + (2S) -2-isopropyl-3-oxosuccinate + H + + NADH (2S) -2-isopropyl-3-oxosuccinate + H + 4-methyl-2-oxopentanoate + CO 2
ʻO Theaflavin-3-gallate: ʻO Theaflavin-3-gallate kahi mea loaʻa mai ka theaflavin. Hiki ke loaʻa i ke kī ʻeleʻele.
3J: E kuhikuhi paha ʻo 3J i: 3J , kahi ʻano ma nā mea pili ʻohana Hōʻailona 3j a i ʻole nā ​​hōʻailona Wigner 3-jm, nā hōʻailona ma nā mīkini mekanika Zip (airline) 's IATA code ʻO ka code IATA o Jubba Airways 3 J, kahi ʻano o ka hoʻopili J e hoʻopili ana i nā paʻa 3 i ka resonance ʻume mākenēki
3K: E nānā paha ʻo 3K a i ʻole 3-K i: 3Kingdoms , kahi MUD, a i ʻole ke pāʻani ʻana ma ka pūnaewele ma ke ʻano pāʻani Mea hoʻolālā mokulele IATA no Jetstar Asia Airways Ku Klux Klan ʻO 3K , kahi kahawai mua o Radio Television o Serbia. Nā hoʻonā ʻoniʻoni kikoʻī 3K, e ʻike i ka papa inoa o nā hoʻonā maʻamau. Kinder, Küche, bKirche ʻO Kitanai, kiken, a me kitsui, kahi papa hana 3000 (helu) 3K, ʻenekini Toyota K Pūʻali 3K SSH 3K (WA), e ʻike iā Wakinekona Ala Ala 128 Pāhawewe 3K, e ʻike i ka radiation radiation latar honua o Cosmic PI-3K, e ʻike iā Phosphoinositide 3-kinase Python 3K, e ʻike iā Python F6F-3K Hellcat, kahi hiʻohiʻona o Grumman F6F Hellcat ʻO Mystery Science Theatre 3K, e ʻike i ka Mystery Science Theatre 3000 3k, track and field shorthand no 3000 mau mika ʻĀina EIF3K ʻO Jetstar Asia mea hoʻolālā IATA.
3-Keto-5a-abiraterone: ʻO 3-Keto-5α-abiraterone , i ʻike ʻia ma ke ʻano he 17- (3-pyridyl) -5α-androst-16-en-3-one , he metabolite ʻeleu o ka abiraterone acetate i loaʻa i loaʻa ka hana androgenic a hoʻoulu i ka prostate. holomua maʻi ʻaʻai. Hana ʻia penei: abiraterone acetate i abiraterone e nā esterases; abiraterone i Δ 4 -abiraterone na 3β-hydroxysteroid dehydrogenase / Δ 5-4 isomerase ; a Δ 4 -abiraterone i 3-keto-5α-abiraterone na 5α-reductase. Hiki iā 3-Keto-5α-abiraterone ke pale aku i ka pono olakino o abiraterone acetate, a no laila ke ʻimi ʻia nei ka pāpā ʻana o kāna hoʻokumu ʻana me ka hoʻohana ʻana i ka mea hōʻoki 5α-reductase dutasteride ma ke ʻano he mea kōkua i ka abiraterone acetate i ka mālama ʻana i ka maʻi ʻaʻai prostate
5α-Dihydronorethandrolone: 5α-Dihydronorethandrolone ( 5α-DHNED ), ʻike ʻia ʻo 17α-ethyl-4,5α-dihydro-19-nortestostero a i ʻole 17α-ethyl-5α-estran-17β-ol-3-one , he androgen / anabolic steroid a kahi metabolite o norethandrolone i hana ʻia e 5α-reductase. Analogously i nandrolone a me kona 5α-hoʻoliʻiliʻi metabolite 5α-dihydronandrolone, 5α-DHNED hōʻike hoʻemi i ka pilina no ka androgen receptor e pili ana i norethandrolone. ʻO kāna pilina no ka receptor androgen kikoʻī ma kahi o 64% o ko norethandrolone.
5α-Dihydronorethandrolone: 5α-Dihydronorethandrolone ( 5α-DHNED ), ʻike ʻia ʻo 17α-ethyl-4,5α-dihydro-19-nortestostero a i ʻole 17α-ethyl-5α-estran-17β-ol-3-one , he androgen / anabolic steroid a kahi metabolite o norethandrolone i hana ʻia e 5α-reductase. Analogously i nandrolone a me kona 5α-hoʻoliʻiliʻi metabolite 5α-dihydronandrolone, 5α-DHNED hōʻike hoʻemi i ka pilina no ka androgen receptor e pili ana i norethandrolone. ʻO kāna pilina no ka receptor androgen kikoʻī ma kahi o 64% o ko norethandrolone.
5α-Dihydronorethandrolone: 5α-Dihydronorethandrolone ( 5α-DHNED ), ʻike ʻia ʻo 17α-ethyl-4,5α-dihydro-19-nortestostero a i ʻole 17α-ethyl-5α-estran-17β-ol-3-one , he androgen / anabolic steroid a kahi metabolite o norethandrolone i hana ʻia e 5α-reductase. Analogously i nandrolone a me kona 5α-hoʻoliʻiliʻi metabolite 5α-dihydronandrolone, 5α-DHNED hōʻike hoʻemi i ka pilina no ka androgen receptor e pili ana i norethandrolone. ʻO kāna pilina no ka receptor androgen kikoʻī ma kahi o 64% o ko norethandrolone.
5α-Dihydronorethandrolone: 5α-Dihydronorethandrolone ( 5α-DHNED ), ʻike ʻia ʻo 17α-ethyl-4,5α-dihydro-19-nortestostero a i ʻole 17α-ethyl-5α-estran-17β-ol-3-one , he androgen / anabolic steroid a kahi metabolite o norethandrolone i hana ʻia e 5α-reductase. Analogously i nandrolone a me kona 5α-hoʻoliʻiliʻi metabolite 5α-dihydronandrolone, 5α-DHNED hōʻike hoʻemi i ka pilina no ka androgen receptor e pili ana i norethandrolone. ʻO kāna pilina no ka receptor androgen kikoʻī ma kahi o 64% o ko norethandrolone.
Norethandrolone: ʻO Norethandrolone , kūʻai ʻia ma lalo o nā inoa inoa Nilevar a me Pronabol i waena o nā mea ʻē aʻe, he lāʻau androgen a me ka anabolic steroid (AAS) i hoʻohana ʻia e hāpai i ka ulu ʻana o nā mākala a mālama i nā ʻā nui, nā ʻeha kino, a me nā anemia aplastic akā ua hoʻopau ʻia ka hapa nui. Loaʻa ia no ka hoʻohana ma Palani akā naʻe. Lawe ʻia e ka waha.
ʻO Levonorgestrel acetate: ʻO Levonorgestrel acetate ( LNG-A ), a i ʻole levonorgestrel 17β-acetate , i ʻike ʻia ʻo 3-ketonorgestimate , kahi progestin ʻaʻole i kūʻai ʻia aku. He ester progestogen ia a ʻo ia ka ester C17β acetate a me kahi mea hana o levonorgestrel. ʻO Norgestimate ka C3 oxime o LNG-A. ʻO ka lāʻau lapaʻau kahi metabolite hana nui o norgestimate, kahi mea hana o norelgestromin a i kahi liʻiliʻi o levonorgestrel a me LNG-A. He pilina kiʻekiʻe ʻo LNG-A no ka progesterone receptor, ma kahi o 135% o kēlā promegestone. Me ka levonorgestrel butanoate, ua noiʻi ʻia ʻo LNG-A ma ke ʻano he contraceptive hormonal e ka Populate Council.
3-Ketosteroid hōʻemi: I loko o ka enzymology, kahi 3-keto-steroid reductase (EC 1.1.1.270 ) kahi enzyme e catalyze i ka hopena kemika 4alpha-methyl-5alpha-cholest-7-en-3beta-ol + NADP + 4alpha-methyl-5alpha-cholest-7-en-3-one + NADPH + H +
3-Oxoacyl-CoA: ʻO 3-Oxoacyl-CoA kahi hui o nā coenzymes e pili ana i ka metabolism o nā momona momona.
17α-Allyl-19-ʻākau: 17α-Allyl-19-nortestosterone , ʻike ʻia ʻo 3-ketoallylestrenol a i ʻole ʻo 17α-allylestr-4-en-17β-ol-3-one , kahi progestin i kūʻai ʻole ʻia aku. He hua hoʻohui ia o ka anabolic-androgenic steroid a me progestogen nandrolone (19-nortestolone) a me ka antiandrogen allyltestolone (17α-allyltestolone). ʻO ka lāʻau lapaʻau kahi metabolite hana nui o allylestrenol, i manaʻo ʻia he prodrug o 17α-allyl-19-nortestosteron.
17α-Allyl-19-ʻākau: 17α-Allyl-19-nortestosterone , ʻike ʻia ʻo 3-ketoallylestrenol a i ʻole ʻo 17α-allylestr-4-en-17β-ol-3-one , kahi progestin i kūʻai ʻole ʻia aku. He hua hoʻohui ia o ka anabolic-androgenic steroid a me progestogen nandrolone (19-nortestolone) a me ka antiandrogen allyltestolone (17α-allyltestolone). ʻO ka lāʻau lapaʻau kahi metabolite hana nui o allylestrenol, i manaʻo ʻia he prodrug o 17α-allyl-19-nortestosteron.
Norethandrolone: ʻO Norethandrolone , kūʻai ʻia ma lalo o nā inoa inoa Nilevar a me Pronabol i waena o nā mea ʻē aʻe, he lāʻau androgen a me ka anabolic steroid (AAS) i hoʻohana ʻia e hāpai i ka ulu ʻana o nā mākala a mālama i nā ʻā nui, nā ʻeha kino, a me nā anemia aplastic akā ua hoʻopau ʻia ka hapa nui. Loaʻa ia no ka hoʻohana ma Palani akā naʻe. Lawe ʻia e ka waha.
Norethisterone: ʻO Norethisterone , i ʻike ʻia ma ke ʻano he norethindrone a kūʻai ʻia ma lalo o nā inoa inoa he nui, he lāʻau lapaʻau progestin i hoʻohana ʻia i nā lāʻau kaohi hānau, menopausal hormone therapy, a no ka mālama ʻana i nā maʻi gynecological. Loaʻa ka lāʻau i loko o nā haʻina haʻahaʻa a me nā kaha kiʻekiʻe a me nā mea ʻelua a me ka hui pū ʻia me ka estrogen. Hoʻohana ʻia ia e ka waha a i ʻole, ma ke ʻano he norethisterone enanthate, e ka pahu ʻana i kaʻiʻo.
Norethisterone: ʻO Norethisterone , i ʻike ʻia ma ke ʻano he norethindrone a kūʻai ʻia ma lalo o nā inoa inoa he nui, he lāʻau lapaʻau progestin i hoʻohana ʻia i nā lāʻau kaohi hānau, menopausal hormone therapy, a no ka mālama ʻana i nā maʻi gynecological. Loaʻa ka lāʻau i loko o nā haʻina haʻahaʻa a me nā kaha kiʻekiʻe a me nā mea ʻelua a me ka hui pū ʻia me ka estrogen. Hoʻohana ʻia ia e ka waha a i ʻole, ma ke ʻano he norethisterone enanthate, e ka pahu ʻana i kaʻiʻo.
Norethisterone: ʻO Norethisterone , i ʻike ʻia ma ke ʻano he norethindrone a kūʻai ʻia ma lalo o nā inoa inoa he nui, he lāʻau lapaʻau progestin i hoʻohana ʻia i nā lāʻau kaohi hānau, menopausal hormone therapy, a no ka mālama ʻana i nā maʻi gynecological. Loaʻa ka lāʻau i loko o nā haʻina haʻahaʻa a me nā kaha kiʻekiʻe a me nā mea ʻelua a me ka hui pū ʻia me ka estrogen. Hoʻohana ʻia ia e ka waha a i ʻole, ma ke ʻano he norethisterone enanthate, e ka pahu ʻana i kaʻiʻo.
ʻO Levonorgestrel acetate: ʻO Levonorgestrel acetate ( LNG-A ), a i ʻole levonorgestrel 17β-acetate , i ʻike ʻia ʻo 3-ketonorgestimate , kahi progestin ʻaʻole i kūʻai ʻia aku. He ester progestogen ia a ʻo ia ka ester C17β acetate a me kahi mea hana o levonorgestrel. ʻO Norgestimate ka C3 oxime o LNG-A. ʻO ka lāʻau lapaʻau kahi metabolite hana nui o norgestimate, kahi mea hana o norelgestromin a i kahi liʻiliʻi o levonorgestrel a me LNG-A. He pilina kiʻekiʻe ʻo LNG-A no ka progesterone receptor, ma kahi o 135% o kēlā promegestone. Me ka levonorgestrel butanoate, ua noiʻi ʻia ʻo LNG-A ma ke ʻano he contraceptive hormonal e ka Populate Council.
3-Ketosteroid 9alpha-monooxygenase: ʻO 3-ketosteroid 9alpha-monooxygenase (EC 1.14.13.142 , KshAB , 3-ketosteroid 9alpha-hydroxylase ) kahi enzyme me ka inoa ʻōnaehana androsta-1,4-diene-3,17-dione, NADH: oxygen oxidoreductase (9alpha-hydroxylating) . Hoʻopili kēia enzyme i ka hopena kemika i lalo androsta-1,4-diene-3,17-dione + NADH + H + + O 2 9alpha-hydroxyandrosta-1,4-diene-3,17-dione + NAD + + H 2 O
3-Ketosteroid hōʻemi: I loko o ka enzymology, kahi 3-keto-steroid reductase (EC 1.1.1.270 ) kahi enzyme e catalyze i ka hopena kemika 4alpha-methyl-5alpha-cholest-7-en-3beta-ol + NADP + 4alpha-methyl-5alpha-cholest-7-en-3-one + NADPH + H +
3 Nā Aupuni: ʻO 3Kingdoms , hoʻopōkole ʻia ʻo 3K , kahi MUD, kahi pāʻani pāʻani pāʻani pūnaewele e hoʻokumu ʻia ma 1992.
3L: E nānā paha ʻo 3L a i ʻole 3-L i: 3L, a i ʻole Economic Synergy, kahi hui politika ma Hong Kong ʻO ke haumāna kula kānāwai makahiki ʻekolu (hope loa) ma United States Federal Election Commission (FEC) Palapala 3L, a i ʻole ka hōʻike o nā hāʻawi i hoʻopili ʻia e nā Lobbyists, kahi e hōʻike ai nā hoʻolaha pekelala a me nā kōmike i kekahi mau makana i loaʻa i ka FEC i nā manawa mau. 3L, kahi laʻana o ka ʻenekini diesel Toyota L ʻehā-ʻolokaʻa ʻO Ford 3L GT a i ʻole F3L, kahi hoʻohālikelike kaʻa hoʻokūkū hoʻokūkū haʻuki i hoʻolauna ʻia i Malaki 1968 Bentley 3L a i ʻole Bentley 3 Liter, kahi kaʻa haʻuki 1920s SSH 3L a i ʻole Secondary State Highway 3L, kahi ala i lilo i Wakinekona Mokuʻāina Ala 126 Lupo 3L, kahi hoʻohālikelike o ka kaʻa ʻo Volkswagen Lupo SEAT Arosa 3L, kahi hiʻohiʻona o ke kaʻa SEAT Arosa ʻO Curtiss HS-3L, kahi moku lele lele hoʻokahi i kūkulu ʻia no ka ʻAmelika Hui Pū ʻIa i ka wā o ke Kaua Honua I
3-Länder-huakaʻi: ʻO ka 3-Länder-Tour der Sparkassen Versicherung kahi heihei keke waʻa nunui i mālama ʻia ma kahi o ʻekolu Länder o Kelemania: Hessen, Thuringia a me Baden-Württemberg. Mai ka 2005 a hiki i ka 2007 he ʻāpana ia o ka UCI Europe Tour, i hoʻonohonoho ʻia ma ke ʻano he heihei 2.1.
3-Länder-huakaʻi: ʻO ka 3-Länder-Tour der Sparkassen Versicherung kahi heihei keke waʻa nunui i mālama ʻia ma kahi o ʻekolu Länder o Kelemania: Hessen, Thuringia a me Baden-Württemberg. Mai ka 2005 a hiki i ka 2007 he ʻāpana ia o ka UCI Europe Tour, i hoʻonohonoho ʻia ma ke ʻano he heihei 2.1.
3-Länder-huakaʻi: ʻO ka 3-Länder-Tour der Sparkassen Versicherung kahi heihei keke waʻa nunui i mālama ʻia ma kahi o ʻekolu Länder o Kelemania: Hessen, Thuringia a me Baden-Württemberg. Mai ka 2005 a hiki i ka 2007 he ʻāpana ia o ka UCI Europe Tour, i hoʻonohonoho ʻia ma ke ʻano he heihei 2.1.
3-Länder-huakaʻi: ʻO ka 3-Länder-Tour der Sparkassen Versicherung kahi heihei keke waʻa nunui i mālama ʻia ma kahi o ʻekolu Länder o Kelemania: Hessen, Thuringia a me Baden-Württemberg. Mai ka 2005 a hiki i ka 2007 he ʻāpana ia o ka UCI Europe Tour, i hoʻonohonoho ʻia ma ke ʻano he heihei 2.1.
3-Länder-huakaʻi: ʻO ka 3-Länder-Tour der Sparkassen Versicherung kahi heihei keke waʻa nunui i mālama ʻia ma kahi o ʻekolu Länder o Kelemania: Hessen, Thuringia a me Baden-Württemberg. Mai ka 2005 a hiki i ka 2007 he ʻāpana ia o ka UCI Europe Tour, i hoʻonohonoho ʻia ma ke ʻano he heihei 2.1.
3-Länder-huakaʻi: ʻO ka 3-Länder-Tour der Sparkassen Versicherung kahi heihei keke waʻa nunui i mālama ʻia ma kahi o ʻekolu Länder o Kelemania: Hessen, Thuringia a me Baden-Württemberg. Mai ka 2005 a hiki i ka 2007 he ʻāpana ia o ka UCI Europe Tour, i hoʻonohonoho ʻia ma ke ʻano he heihei 2.1.
3M: ʻO ka Hui 3M kahi hui multinational conglomerate ʻAmelika Hui Pū ʻIa e hana ana i nā māla o ka ʻoihana, ka palekana o nā limahana, ka mālama olakino US, a me nā huahana mea kūʻai aku. Hana ka hui ma luna o nā huahana 60,000 ma lalo o kekahi mau lama, e like me nā mea hoʻopili, abrasives, laminate, pale ahi passive, pono ponoʻī pilikino, puka ʻoniʻoni, nā kiʻi pale pena, nā huahana niho a me nā orthodontic, nā uila a me nā uila e hoʻopili ana a me nā mea pilikino, nā huahana olakino, kaʻa- nā huahana mālama, nā kaʻa uila, nā polokalamu olakino a me nā kiʻi ʻoniʻoni. Aia ia ma Maplewood, kahi kaiāulu o Saint Paul, Minnesota.
3-Monoacetylmorphine: 3-Monoacetylmorphine ( 3-MAM ) a i ʻole 3-acetylmorphine kahi metabolite liʻiliʻi o ka heroin (diacetylmorphine), ʻo nā mea ʻelua he morphine a ʻoi aku ka 6-monoacetylmorphine (6-MAM).
3-Methylbutyrfentanyl: 3-Methylbutyrfentanyl ( 3-MBF ) he analgesic opioid kahi analog o butyrfentanyl.
3-Methylcrotonyl-CoA hemahema carboxylase: 3-Methylcrotonyl-CoA hemahema carboxylase i ʻike ʻia ʻo 3-Methylcrotonylglycinuria a i ʻole BMCC hemahema kahi maʻi hoʻoilina i hiki ʻole i ke kino ke hana pono i kekahi mau protein. Loaʻa i nā poʻe me kēia maʻi ka lawa ʻole o ka pae o ka enzyme e kōkua ana e wāwahi i nā protein i loaʻa ka leucine amino acid. Hoʻopili kēia ʻano i ka 1 i manaʻo ʻia ma 50,000 poʻe ma ka honua holoʻokoʻa.
3-MCPD: ʻO 3-MCPD ( 3-monochloropropane-1,2-diol a i ʻole 3-chloropropane-1,2-diol ) kahi hui kemika kūlohelohe me ke ʻano HOCH 2 CH (OH) CH 2 Cl. He wai kala ʻole ia. He palau hale multifunctional maʻalahi ia. Ua ʻumeʻume ka hui i ka nānā ma ke ʻano he lālā maʻamau o nā mea hoʻoweliweli ʻai kemika i kapa ʻia ʻo chloropropanols. Manaʻo ʻia he carcinogenic i loko o nā kānaka.
3-Methylmethcathinone: ʻO 3-Methylmethcathinone , a i ʻike ʻia ma ke ʻano he 3-MMC a me Metaphedrone , kahi lāʻau hoʻolālā mai ka ʻohana cathinone pani. Pili pili loa ʻo 3-MMC i ke ʻano o ka mephedrone lāʻau lapaʻau pinepine ʻia (4-MMC), a he kūpono ʻole ia i ka hapa nui o nā ʻāina i pāpā aku iā mephedrone ʻoiai he isomer hoʻolālā ia o ia. Eia nō naʻe, ua hōʻike ʻia ʻo 3-MMC ma ka mākeke lāʻau leʻaleʻa ma ke ʻano he ʻokoʻa i ka mephedrone, a ua ʻike mua ʻia e kūʻai ʻia ana ma Suedena i ka makahiki 2012. ʻAʻole like me nā kiʻekiʻe kiʻekiʻe ma ke kānāwai ʻo 3-MMC i hoʻāʻo ʻia a hōʻike ʻia i loko o nā māmela nui, e hāʻawi ana i ka ʻike hou aku e pili ana ʻo ia ma mua o ka ʻike e pili ana i nā cathinones synthetic. ʻO 3-MMC kahi substrate transporter monoamine e kāohi pono i ka norepinephrine i ka lawe a hōʻike i ka nui o ka dopamineergic me ka hana serotonergic.
3-M maʻi: 3-M syndrome a i ʻole 3M3 kahi maʻi hoʻoilina i ʻike pinepine ʻia e ka retardation ulu ulu nui, dysmorfia helehelena, a me nā kino iwi ʻole. Loaʻa ka inoa 3-M mai nā hua mua o nā mea noiʻi ʻekolu i ʻike mua iā ia: Miller, McKusick, a me Malvaux a hōʻike i kā lākou loaʻa i nā puke lapaʻau i ka makahiki 1972. ʻO nā hoʻololi ʻana i kekahi o nā ʻano aʻe ʻekolu: CUL7 , OBSL1 , a ʻo CCDC8 ke kuleana no ka hanana o kēia maʻi. Ua hoʻoilina ia ma o kahi autessomal recessive pattern a manaʻo ʻia he kākaʻikahi loa, ma lalo o 100 mau hihia a puni ka honua i ʻike ʻia. Hoʻokumu ʻia ka hōʻailona ma ke kū ʻana o nā hiʻohiʻona maʻi. Hiki i nā hoʻokolohua genetic ke hōʻoia i ka hōʻailona a ʻike i ka ʻāpana kikoʻī e pili ana. Hoʻonohonoho ʻia ka mālama ʻana i ka hoʻoponopono ʻana i nā pilikia o ka ulu a me nā iwi a hiki paha ke hoʻopili i ka hoʻolōʻihi ʻia ʻana o ka iwi ʻokiʻoki, nā mea kōkua adaptive, a me ka hoʻoponopono kino. Hiki i kahi endocrinologist ke kōkua me ka hormonone ulu hou a me nā loiloi kūpono i ka wā ʻōpio.
3-M maʻi: 3-M syndrome a i ʻole 3M3 kahi maʻi hoʻoilina i ʻike pinepine ʻia e ka retardation ulu ulu nui, dysmorfia helehelena, a me nā kino iwi ʻole. Loaʻa ka inoa 3-M mai nā hua mua o nā mea noiʻi ʻekolu i ʻike mua iā ia: Miller, McKusick, a me Malvaux a hōʻike i kā lākou loaʻa i nā puke lapaʻau i ka makahiki 1972. ʻO nā hoʻololi ʻana i kekahi o nā ʻano aʻe ʻekolu: CUL7 , OBSL1 , a ʻo CCDC8 ke kuleana no ka hanana o kēia maʻi. Ua hoʻoilina ia ma o kahi autessomal recessive pattern a manaʻo ʻia he kākaʻikahi loa, ma lalo o 100 mau hihia a puni ka honua i ʻike ʻia. Hoʻokumu ʻia ka hōʻailona ma ke kū ʻana o nā hiʻohiʻona maʻi. Hiki i nā hoʻokolohua genetic ke hōʻoia i ka hōʻailona a ʻike i ka ʻāpana kikoʻī e pili ana. Hoʻonohonoho ʻia ka mālama ʻana i ka hoʻoponopono ʻana i nā pilikia o ka ulu a me nā iwi a hiki paha ke hoʻopili i ka hoʻolōʻihi ʻia ʻana o ka iwi ʻokiʻoki, nā mea kōkua adaptive, a me ka hoʻoponopono kino. Hiki i kahi endocrinologist ke kōkua me ka hormonone ulu hou a me nā loiloi kūpono i ka wā ʻōpio.
3-Maleylpyruvic acid: ʻO ka 3-Maleylpyruvic acid , a i ʻole 3-maleylpyruvate , kahi waikawa dicarboxylic i hoʻokumu ʻia e ka wehe ʻana o ke apo oxidative o ka waikawa gentisic e ka 1,2-dioxygenase gentisate i ka wā o ka metabolism o tyrosine. Hoʻohuli ʻia i 3-fumarylpyruvate e maleylpyruvate isomerase.
3-Maleylpyruvic acid: ʻO ka 3-Maleylpyruvic acid , a i ʻole 3-maleylpyruvate , kahi waikawa dicarboxylic i hoʻokumu ʻia e ka wehe ʻana o ke apo oxidative o ka waikawa gentisic e ka 1,2-dioxygenase gentisate i ka wā o ka metabolism o tyrosine. Hoʻohuli ʻia i 3-fumarylpyruvate e maleylpyruvate isomerase.
ʻEkolu kāne kūkā: ʻO ka chess ʻekolu mau kāne kahi ʻano chess no nā mea pāʻani ʻekolu i haku ʻia e George R. Dekle Sr. i ka makahiki 1984. Hoʻokani ʻia ka pāʻani ma kahi papa hexagonal e piha ana he 96 mau ʻaoʻao quadrilateral. Mālama kēlā me kēia mea pāʻani i kahi pūʻali koa maʻamau o nā ʻāpana chess.
ʻO Ohmefentanyl: ʻO Ohmefentanyl kahi lāʻau opioid analgesic ikaika loa e hoʻopaʻa paʻa i ka mea loaʻa µ-opioid.
Methoxmetamine: ʻO Methoxmetamine kahi anesthetic dissociative o ka arylcyclohexylamine papa e pili loa ana i ka methoxetamine a me ka methoxyketamine, a ua kūʻai ʻia aku ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā.
MMDA (lāʻau lāʻau): ʻO MMDA kahi lāʻau psychedelic a entactogen o ka papa amphetamine. He analogue ia o ka lophophine, MDA, a me MDMA.
3-MeO-PCE: 3-Methoxyeticyclidine ( 3-MeO-PCE ), i ʻike ʻia he methoxieticyclidine , he anesthetic dissociative i like kona ʻano me PCE a me PCP a ua kūʻai ʻia aku ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā.
3-MeO-PCMo: ʻO 3-MeO-PCMo kahi lāʻau anesthetic dissociative e like me ke ʻano o phencyclidine a kūʻai ʻia aku ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā. ʻO ka hopena kaohi o 3-MeO-PCMo i ka hoʻoliʻiliʻi o ka nui o nā puʻupuʻu drebrin e ka NMDAR stimulate me ka glutamic acid ʻoi aku ka haʻahaʻa ma mua o ka PCP a i ʻole 3-MeO-PCP, me ka hapalua o ka nui o nā koina inhibitory (IC 50 ) o 26.67 μM (3-MeO-PCMo), 2.02 μM (PCP) a me 1.51 μM (3-MeO-PCP).
3-MeO-PCP: 3-Methoxyphencyclidine ( 3-MeO-PCP ) kahi hallucinogen dissociative o ka arylcyclohexylamine papa e pili ana i ka phencyclidine (PCP) i kūʻai ʻia ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā. Hana nui ia ma ke ʻano he antagonist receptor NMDA, ʻoiai ua ʻike ʻia e launa pū me ka receptor sigma σ 1 a me ka transporter serotonin. ʻAʻohe o ka lāʻau i kekahi hana opioid a hana ʻole ia ma ke ʻano he mea hoʻopāpā reoptake.
3-Mercapto-1-propanesulfonic acid: ʻO 3-Mercapto-1-propanesulfonic acid kahi hui kemika i hoʻohana pinepine ʻia ma ke ʻano he brightener i ka electroplating keleawe.
3-Mercapto-3-methylbutan-1-ol: 3-Mercapto-3-methylbutan-1-ol , ʻo MMB kekahi, a thiol a me kahi ʻalekohola. ʻO MMB kahi huahana hoʻohaʻahaʻa o ka amino acid felinine i ka mimi pōpoki a he pheromone pōpoki. Loaʻa pū ʻia ʻo Mbb i nā waina Sauvignon blanc me nā hui e pili ana ʻo 4-mercapto-4-methylpentan-2-ol a me 3-mercaptohexan-1- ol.
Propanethiol: ʻO Propanethiol kahi hui kūmole me ka mole mole C 3 H 8 S. No ka hui o thiols ia. He wai kala ʻole ia me ka ʻaʻala ikaika, hōʻeha hoʻi. He mea ʻawaʻawa kūpono ia a ʻoi aku ka liʻiliʻi ma mua o ka wai a maʻalahi ʻia i ka wai. Hoʻohana ʻia ia ma ke ʻano he meaʻai hānai no nā mea kolo. He wela nui ia a hāʻawi ia i nā ʻāpiki hoʻonāukiuki a ʻona (a i ʻole nā ​​kinoea) i ke ahi. ʻO ka hoʻomehana ʻana ka mea e ala ai ka piʻi me ka makaʻu o ka haki.
3-Merc laptopropane-1,2-diol: ʻO 3-Merc laptopropane-1,2-diol , i kapa ʻia ʻo thioglycerol , kahi hui kemika a me thiol i hoʻohana ʻia ma ke ʻano he mākia i ka spectrometry nuipaukū pōkā nui atom a me ka spectrometry nui wai wai kekona lua.
3-ʻo Mercaptropionic acid: 3-Mercaptopropionicʻakika (3-MPA) mea he organosulfur hui me ka haʻilula HSCH 2 Ch 2 CO 2 H. He He bifunctional lātoma, i loaʻa nā carboxylicʻakika a me thiol pūʻulu. He aila kala ʻole ia. Loaʻa ia mai ka hoʻohui o hydrogen sulfide i ka acrylic acid.
3-ʻo Mercaptropionic acid: ʻO ka 3-Merc laptopropionic acid ( 3-MPA ) kahi hui organosulfur me ke ʻano HSCH 2 CH 2 CO 2 H. He mole ia e hoʻohana ʻia ana, me nā hui ʻakika carboxylic a me nā hui thiol. He aila kala ʻole ia. Loaʻa ia mai ka hoʻohui o hydrogen sulfide i ka acrylic acid.
3-Merc laptopropionitrile: ʻO 3-Merc laptopropionitrile ka hui organosulfur me ke ʻano HSCH 2 CH 2 CN. Loaʻa nā pūʻulu hana thiol a me nitrile, he hui bifunctional ia. ʻO kahi wai kala ʻole, ua loaʻa i ka hui kahi hoʻohana e like me kahi ʻano maskole o thiolate.
3-Mercaptyruvic acid: ʻO ka 3-Merc laptopyruvic acid kahi waena ma ka metabolism cysteine. Ua aʻo ʻia ma ke ʻano he hiki ke mālama ʻia no ka lāʻau make i ka cyanide, akā pōkole loa kona hapalua o ke ola no ka mea e pono ke olakino. Akā, e loiloi ʻia nā prodrugs, e like me sulfanegen, e uku no ka hapa pōkole o ka 3-merc laptopyruvic acid.
MMDA (lāʻau lāʻau): ʻO MMDA kahi lāʻau psychedelic a entactogen o ka papa amphetamine. He analogue ia o ka lophophine, MDA, a me MDMA.
Lophophine: ʻO Lophophine kahi lāʻau psychedelic putative a me entactogen o ka papa methylenedioxyphenethylamine. ʻO ia ka homologue α-demethylated o MMDA, a pili pili loa hoʻi i ka mescaline.
MMDMA: ʻO 5-Methoxy-3,4-methylenedioxymethamphetamine kahi lāʻau hoʻolālā no ka papa methylenedioxyphenethylamine (MDxx) i pani ʻia. ʻAʻoleʻike iki ʻia e pili ana i nā hopena a ʻaʻole i aʻo maʻamau ʻia i nā holoholona.
MMDMA: ʻO 5-Methoxy-3,4-methylenedioxymethamphetamine kahi lāʻau hoʻolālā no ka papa methylenedioxyphenethylamine (MDxx) i pani ʻia. ʻAʻoleʻike iki ʻia e pili ana i nā hopena a ʻaʻole i aʻo maʻamau ʻia i nā holoholona.
MMDA (lāʻau lāʻau): ʻO MMDA kahi lāʻau psychedelic a entactogen o ka papa amphetamine. He analogue ia o ka lophophine, MDA, a me MDMA.
Lophophine: ʻO Lophophine kahi lāʻau psychedelic putative a me entactogen o ka papa methylenedioxyphenethylamine. ʻO ia ka homologue α-demethylated o MMDA, a pili pili loa hoʻi i ka mescaline.
3-Methoxy-4-ethoxyphenethylamine: ʻO MEPEA , a i ʻole 3-methoxy-4-ethoxyphenethylamine , kahi lāʻau psychedelic liʻiliʻi i ʻike ʻia. Ua hana mua ʻia ʻo MEPEA e Alexander Shulgin. I kāna puke PiHKAL , helu ʻia ka mahele palena iki e like me 300 mg, a me ka lōʻihi ʻike ʻole ʻia. Hoʻopuka ʻo MEPEA i kahi ʻano hāpai māmā a me +1 ma ka Shulgin Rating Scale. Aia nā ʻikepili liʻiliʻi loa e pili ana i nā waiwai lāʻau, metabolism, a me nā mea ʻawahia o MEPEA.
3-Methoxy-4-hydroxyhippuric acid: 3-Methoxy-4-hydroxyhippuric acid kekahi o nā metabolite catechins nui i loaʻa i loko o nā kānaka ma hope o ka hoʻohana ʻana i nā infusions kī ʻōmaʻomaʻo.
3-Methoxy-4-hydroxyhippuric acid: 3-Methoxy-4-hydroxyhippuric acid kekahi o nā metabolite catechins nui i loaʻa i loko o nā kānaka ma hope o ka hoʻohana ʻana i nā infusions kī ʻōmaʻomaʻo.
ʻO Vanillylmandelic acid: He waikawa waena ʻo Vanillylmandelic acid ( VMA ) i ka synthesis o nā meaʻala vanilla ʻimi a he metabolite hopena o nā catecholamines. Hana ʻia ia ma o nā metabolites waena.
3-Methoxy-4-hydroxyphenylglycol: 3-Methoxy-4-hydroxyphenylglycol kahi metabolite o ka norepinephrine degradation. I ka lolo, ʻo ia ke metabolite norepinephrine nui. Hoʻokuʻu ʻia i loko o ke koko a me ka wai cerebrospinal, a me kahi laʻana o ke koko o ia mea he hōʻailona paha ia o ka hana ʻōnaehana ʻōnaehana.
3-Methoxy-4-hydroxyphenylglycol: 3-Methoxy-4-hydroxyphenylglycol kahi metabolite o ka norepinephrine degradation. I ka lolo, ʻo ia ke metabolite norepinephrine nui. Hoʻokuʻu ʻia i loko o ke koko a me ka wai cerebrospinal, a me kahi laʻana o ke koko o ia mea he hōʻailona paha ia o ka hana ʻōnaehana ʻōnaehana.
4-Methylphenylisobutylamine: ʻO 4-Methylphenylisobutylamine ( 4-MAB ), ʻo 4-methyl-α-ethylphenethylamine , kahi lāʻau stimulant o ka papa phenethylamine.
3-Methoxy-4-methylamphetamine: 3-Methoxy-4-methylamphetamine ( MMA ) kahi entactogen a me ka lāʻau psychedelic o nā papa phenethylamine a me amphetamine. Ua synthesize mua ʻia ia ma ka makahiki 1970 a ua hui ʻia me he lāʻau lā ma ʻAtalia i nā makahiki he ʻumi. Ua poina nui ʻia ka MMA a hiki i ka hōʻoia hou ʻia ʻana e David E. Nichols ma ke ʻano he neo non-neurotoxic MDMA i ka makahiki 1991, a ua kūʻai lilo ʻia aku ma ke ʻano he lāʻau lapaʻau hoʻolālā ma ka pūnaewele mai ka hopena o 2000 (mau makahiki).
4-Methylmethamphetamine: 4-Methylmethamphetamine ( 4-MMA ) kahi mea hoʻonāukiuki putative a me entactogen lāʻau o ka papa amphetamine. ʻO ia ka analog-deketo analogue o ka mephedrone.
Pterocarpin: ʻO Pterocarpin kahi pterocarpan i loaʻa ma ka Fabaceae species Baphia nitida , Ononis viscosa subsp. breviflora , Pterocarpus spp. , Sophora angustifolia , Sophora substrata lāua ʻo Swartzia madagascariensis .
3-Methoxymethamphetamine: 3-Methoxymethamphetamine , ka mea pili loa i ka 3-methoxyamphetamine a me ka PMMA a kaʻana like i nā hopena e like me ka hoʻokuʻu ʻana o ka monoamine, ʻoiai ʻaʻole i aʻo nui ʻia nā hopena e like me nā lāʻau ʻē aʻe e pili ana. He agonist ʻo ia no TAAR1 kanaka.
Pinostilbene: ʻO Pinostilbene kahi stilbenoid i loaʻa ma Gnetum venosum a i ka ʻili o Pinus sibirica .
3-Methoxyamphetamine: meta -Methoxyamphetamine ( MMA ), ʻo ia hoʻi ʻo 3-methoxyamphetamine ( 3-MA ), kahi lāʻau stimulant mai ka ʻohana amphetamine. Loaʻa iā ia nā hopena e like me nā hoʻokolohua hoʻowahāwahā lāʻau holoholona i ka derivative 4-methoxyamphetamine (PMA) i ʻike nui ʻia, ʻoiai me ka lakene ʻokoʻa o ka hoʻokuʻu ʻana o ka monoamine, he serotonin hui ʻia, dopamine, a me norepinephrine e hoʻokuʻu ana i ka agena ma mua o kahi serotonin hoʻokuʻu pono. e like me PMA. Ua like like ka 3-Methoxyamphetamine ma ka mākeke illicit ma ke ʻano he lāʻau hoʻolālā hoʻolālā i MDMA, ʻoiai ʻoi aku ka liʻiliʻi ma mua o kāna isomer kūlana kaulana. Hoʻopuka ia i ka gepefrine, kahi stimulant naʻau, ma ke ʻano he metabolite nui.
Estrone methyl etera: ʻO Estrone methyl ether , a i ʻole estrone 3-methyl ether , kahi estrogen synthetic a me estrogen ether - kikoʻī, ʻo ka C3 methyl ether o ka estrone - ʻaʻole i kūʻai aku ʻia. Ua hoʻohana ʻia e synthesize i ka mestranol.
3-MeO-PCE: 3-Methoxyeticyclidine ( 3-MeO-PCE ), i ʻike ʻia he methoxieticyclidine , he anesthetic dissociative i like kona ʻano me PCE a me PCP a ua kūʻai ʻia aku ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā.
3-Methoxymethamphetamine: 3-Methoxymethamphetamine , ka mea pili loa i ka 3-methoxyamphetamine a me ka PMMA a kaʻana like i nā hopena e like me ka hoʻokuʻu ʻana o ka monoamine, ʻoiai ʻaʻole i aʻo nui ʻia nā hopena e like me nā lāʻau ʻē aʻe e pili ana. He agonist ʻo ia no TAAR1 kanaka.
3-Methoxymorphinan: ʻO 3-Methoxymorphinan kahi metabolite levomethorphan i hōʻike ʻia e hana i nā hopena anesthetic kūloko. ʻO CYP3A4 metabolite o dextromethorphan, a hana pono ʻia e ka ʻokena akepau CYP2D6.
3-MeO-PCP: 3-Methoxyphencyclidine ( 3-MeO-PCP ) kahi hallucinogen dissociative o ka arylcyclohexylamine papa e pili ana i ka phencyclidine (PCP) i kūʻai ʻia ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā. Hana nui ia ma ke ʻano he antagonist receptor NMDA, ʻoiai ua ʻike ʻia e launa pū me ka receptor sigma σ 1 a me ka transporter serotonin. ʻAʻohe o ka lāʻau i kekahi hana opioid a hana ʻole ia ma ke ʻano he mea hoʻopāpā reoptake.
Methoxyphenol: Hiki paha i ka Methoxyphenol a i ʻole hydroxyanisole ke kuhikuhi iā: 2-Methoxyphenol 3-Methoxyphenol 4-Methoxyphenol
Pinostilbene: ʻO Pinostilbene kahi stilbenoid i loaʻa ma Gnetum venosum a i ka ʻili o Pinus sibirica .
3-Methoxytyramine: 3-Methoxytyramine ( 3-MT ), i ʻike ʻia ʻo 3-methoxy-4-hydroxyphenethylamine , kahi amine kumumea kanaka e kū ma ke ʻano he metabolite o ka neurotransmitter dopamine. Hoʻokumu ʻia ia e ka hoʻolauna ʻana o kahi hui methyl i ka dopamine e ka enzyme catechol-O-methyl transferase (COMT). 3-MT hiki ke hoʻopili hou ʻia e ka enzyme monoamine oxidase (MAO) e hana i ka waikawa homovanillic (HVA), a laila excreted i ka mimi
ʻO ka waiʻona Isoamyl: ʻO ka waiʻona Isoamyl kahi wai kala ʻole me ke ʻano C 5 H 12 O , kikoʻī (H 3 C–) 2 CH – CH 2 –CH 2 –OH. ʻO ia kekahi o nā isomers o ka amyl waiʻona (pentanol). ʻIke ʻia kekahi me ka waiʻona isopentyl , isopentanol , a i ʻole (i ka IUPAC i ʻōlelo ʻia nomenclature) 3-methyl-butan-1-ol . He inoa kahiko no ia ʻo isobutyl carbinol .
Isoamyl acetate: ʻO ka Isoamyl acetate , i ʻike ʻia ʻo isopentyl acetate , kahi hui ʻokanika ʻo ia ka ester i hana ʻia mai isoamyl waiʻona a me acetic acid. He wai kala ʻole ia e hoʻoheheʻe iki ʻia i ka wai, akā hiki ke hoʻoheheʻe ʻia i ka hapa nui o nā mea hoʻoheheʻe. He ʻala ikaika ka Isoamyl acetate i wehewehe ʻia e like me ka maiʻa a me ka pea. ʻO ka isoamyl acetate maʻemaʻe, a i ʻole nā ​​hui ʻana o isoamyl acetate, amyl acetate, a me nā mea ʻono ʻē aʻe e kapa ʻia he aila maiʻa .
3-Methyl-1-pentanol: ʻO ka 3-Methyl-1-pentanol kahi hui kemikaola . Kū kūlohelohe ia i nā frutescens Capsicum , ka pepa kapu tabasco.
3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol: 3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol he synthetic, steroidal estrogen a me kahi agonist wae o ka ERβ. Ua ʻike ʻia serendipitous a ʻo ia ka mea alakaʻi alakaʻi i waena o kahi o androsta-3,5-dienes ma ke ʻano he ligand ERβ. ʻO kāna pilina ( IC 50 ) no ka ERβ i ʻike ʻia he 9 nM a ua hōʻike ʻia i ka 62 a me ka 160 pāliki paʻa paʻa ʻana no kēia mea loaʻa ma luna o ka AR a me ka ERα. ʻO ka EC 50 o ka hui no ka ERβ i loaʻa he 69 nM a ʻo kāna hana intrinsic he 92% (e pili ana i ka estradiol). E like me ia, he agonist ERβ ikaika me ke aloha kiʻekiʻe a me ka selectivity.
3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol: 3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol he synthetic, steroidal estrogen a me kahi agonist wae o ka ERβ. Ua ʻike ʻia serendipitous a ʻo ia ka mea alakaʻi alakaʻi i waena o kahi o androsta-3,5-dienes ma ke ʻano he ligand ERβ. ʻO kāna pilina ( IC 50 ) no ka ERβ i ʻike ʻia he 9 nM a ua hōʻike ʻia i ka 62 a me ka 160 pāliki paʻa paʻa ʻana no kēia mea loaʻa ma luna o ka AR a me ka ERα. ʻO ka EC 50 o ka hui no ka ERβ i loaʻa he 69 nM a ʻo kāna hana intrinsic he 92% (e pili ana i ka estradiol). E like me ia, he agonist ERβ ikaika me ke aloha kiʻekiʻe a me ka selectivity.
Skatole: ʻO Skatole a i ʻole 3-methylindole kahi hui kūloko ʻohana o ka ʻohana indole. Kū maʻamau ia i nā feces o nā māmela a me nā manu aʻo ia ka mea hāʻawi mua i ka pilau fecal. I nā hoʻohaʻahaʻa haʻahaʻa, he ala pua kona a loaʻa i loko o nā pua a me nā aila pono, e like me nā pua ʻalani, jasmine, a me Ziziphus mauritiana .
3-Methyl-2-butanol: ʻO ka 3-Methyl-2-butanol kahi hui kemikaola. Hoʻohana ʻia ia ma ke ʻano he mea hoʻoheheʻe a waena ma ka hana ʻana i nā kemika ʻē aʻe.
Methyl isopropyl ketone: 3-Methyl-2-butanone kahi ketone a me ka mea hoʻoheheʻe o ka mea nui liʻiliʻi. Hoʻohālikelike ʻia ia me MEK, akā loaʻa ka solvency haʻahaʻa a ʻoi aku ka pipiʻi.
Prenol: ʻO Prenol , a i ʻole 3-methyl-2-buten-1-ol , kahi ʻona maoli. ʻO ia kekahi o nā terpenoids maʻalahi loa. He aila kala ʻole maopopo ia e hiki ke hoʻoheheʻe kūpono ʻia i ka wai a miscible me nā mea hoʻoheheʻeolaolaola maʻamau. He pilau kona hua a hoʻohana ʻia i kekahi manawa i ka mea ʻala.
3-methyl-2-oxobutanoate dehydrogenase (acetyl-hoʻoili) kinase: I loko o ka enzymology, he [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kahi ʻākena e catalyze i ka hopena kemika ATP + [3-methyl-2-oxobutanoate dehydrogenase (acetyl-hoʻoili)] ADP + [3-methyl-2-oxobutanoate dehydrogenase (acetyl-hoʻoili)] phosphate
3-Methyl-2-pentanol: ʻO ka 3-Methyl-2-pentanol kahi mea hoʻohui kemikaola. Ua ʻike ʻia ma ke ʻano he lālā o nā hop. Hiki ke hoʻohana ʻia kona kū ʻana i ka mimi e hoʻāʻo no ka hōʻike ʻana i ka 3-methylpentane.
3-Methyl-2-pentanone: ʻO 3-Methyl-2-pentanone kahi ketone aliphatic a me isomer o 2-hexanone. Hoʻohana ʻia ia ma ke ʻano he mea hoʻoheheʻe a ma ke ʻano waena no nā synthes. He haʻahaʻa kāna ʻoihana ʻenehana. Hana ʻia ia e ka conduction aldol base-catalyzed o 2-butanone me ka acetaldehyde, e hana ana i 4-hydroxy-3-methyl-2-pentanone, i hoʻomaloʻo ʻia i 3-methyl-3-penten-2-hoʻokahi ma luna o kahi cataly acid, i ukali ʻia e ka hydrogenation ma luna o kahi catall catalyst.
Rosefuran: ʻO Rosefuran (3-methyl-2-prenylfuran) kahi wai e hoʻolapalapa ana ma 103-104 ° C, me ka mānoanoa o 0.9089 g / cm3, ʻoi aku ka liʻiliʻi o ka wai. He mea ʻala onaona kahi mea ʻona liʻiliʻi o ka ʻala o ka pua rose. ʻO Rosefuran kahi 2,3-disubstituted furan. He paepae ʻala kona o 200 ppb a lilo i 0.16% o ka ʻaila rose Bulgarian. Ua hoʻokumu ʻia ʻo Rosefuran ma ke ʻano he wahine wahine pheromone o kahi mite acarid, Caloglyphus sp. ʻO nā kuko ma lalo o 100 ng o ka synthetic rosefuran ka mea i hoʻokumu i ka moekolohe i nā kāne o kēia ʻano.
Beta-Hydroxy beta-methylbutyric acid: β-Hydroxy β-methylbutyric acid ( HMB ), a i ʻole kapa ʻia kona kumu conjugate, hydro-hydroxy met-methylbutyrate , he mea hana i hana ʻia i loko o nā kānaka i hoʻohana ʻia ma ke ʻano he hoʻopiha papaʻai a ma ke ʻano he mea hoʻohui i kekahi mau meaʻai olakino i manaʻo ʻia e hoʻolauna i ka hōʻeha ʻana i ka ʻeha a hāʻawi i ke kākoʻo olakino no ka poʻe me ka ʻānai ʻana i nā mākala ma muli o ka maʻi ʻaʻai a i ʻole HIV / AIDS. I nā mākua olakino, hōʻike ʻia ka supplementation me ka HMB e hoʻonui i ka loaʻa o ka hoʻoikaika kino i ka nui o ka mākala, ka ikaika o ka mākala, a me ka nui o ke kino wīwī, hoʻoliʻiliʻi i ka hōʻino ʻana o nā iwi iwi mai ka hoʻoikaika kino ʻana, hoʻomaikaʻi i ka hana hoʻoikaika aerobic, a me ka hoʻolalelale i ke ola ʻana mai ka hoʻoikaika kino. Hōʻike nā loiloi olakino a me nā meta-analithes i ke kōkua ʻana o ka kākoʻo HMB i ka mālama a hoʻonui ʻana paha i ka nui o nā kino o ka momona a me ka ikaika o nā mākala i kēlā me kēia kanaka e ʻike nei i ka nalo ʻana o nā mākala e pili ana i ka makahiki. Hana ka HMB i kēia mau hopena i kahi ʻāpana e ka hoʻonāukiuki ʻana i ka hana o nā protein a me ka pāpā ʻana i ka haki ʻana o nā proteins i kaʻiʻo muscle. ʻAʻole i loaʻa nā hopena maikaʻi ʻole mai ka hoʻohana wā lōʻihi ma ke ʻano he papaʻai meaʻai i nā mākua.
Beta-Hydroxy beta-methylbutyric acid: β-Hydroxy β-methylbutyric acid ( HMB ), a i ʻole kapa ʻia kona kumu conjugate, hydro-hydroxy met-methylbutyrate , he mea hana i hana ʻia i loko o nā kānaka i hoʻohana ʻia ma ke ʻano he hoʻopiha papaʻai a ma ke ʻano he mea hoʻohui i kekahi mau meaʻai olakino i manaʻo ʻia e hoʻolauna i ka hōʻeha ʻana i ka ʻeha a hāʻawi i ke kākoʻo olakino no ka poʻe me ka ʻānai ʻana i nā mākala ma muli o ka maʻi ʻaʻai a i ʻole HIV / AIDS. I nā mākua olakino, hōʻike ʻia ka supplementation me ka HMB e hoʻonui i ka loaʻa o ka hoʻoikaika kino i ka nui o ka mākala, ka ikaika o ka mākala, a me ka nui o ke kino wīwī, hoʻoliʻiliʻi i ka hōʻino ʻana o nā iwi iwi mai ka hoʻoikaika kino ʻana, hoʻomaikaʻi i ka hana hoʻoikaika aerobic, a me ka hoʻolalelale i ke ola ʻana mai ka hoʻoikaika kino. Hōʻike nā loiloi olakino a me nā meta-analithes i ke kōkua ʻana o ka kākoʻo HMB i ka mālama a hoʻonui ʻana paha i ka nui o nā kino o ka momona a me ka ikaika o nā mākala i kēlā me kēia kanaka e ʻike nei i ka nalo ʻana o nā mākala e pili ana i ka makahiki. Hana ka HMB i kēia mau hopena i kahi ʻāpana e ka hoʻonāukiuki ʻana i ka hana o nā protein a me ka pāpā ʻana i ka haki ʻana o nā proteins i kaʻiʻo muscle. ʻAʻole i loaʻa nā hopena maikaʻi ʻole mai ka hoʻohana wā lōʻihi ma ke ʻano he papaʻai meaʻai i nā mākua.
3-Methyl-3-ʻoketana: 3-Methyl-3-octanol ( ʻōnaehana i kapa ʻia ʻo 3-methyloctan-3-ol ) kahi mea hui pū me ke ʻano kemika CH 3 (CH 2 ) 4 C (CH 3 ) (CH 2 CH 3 ) OH (kākau ʻia ʻo C 9 H 20 O ). ʻO kēia wai ʻona ʻokoʻa loa he wai ʻole kala ʻole ia ma lalo o nā kūlana maʻamau, a ʻaʻohe ono.
3-Methyl-3-pentanol: ʻO ka 3-Methyl-3-pentanol kahi mea hoʻohui kemikaola a hexanol tertiary. Hoʻohana ʻia ia i ka synthesive o ka tranquilizer emylcamate, a he ʻano sedative a anticonvulsant nō hoʻi nā hana.
3-Methyl-3-penten-2-hoʻokahi: 3-Methyl-3-penten-2-one kahi ketone aliphatic unsaturated. He isomer ia o mesityl oxide a me isomesityl oxide. He precursor ia o 3-methyl-2-pentanone a loaʻa ʻia e ka dehydration acid-catalyzed o 4-hydroxy-3-methyl-2-pentanone. Hoʻohana ʻia ia ma waena o nā kemika kemika kemika.
5-Methyl-MDA: 5-Methyl-3,4-methylenedioxyamphetamine ( 5-Methyl-MDA ) kahi entactogen a me ka lāʻau hoʻolālā psychedelic o ka papa amphetamine. He homologue kani-methylated o MDA a me kahi isomer kūkulu o MDMA.